by John A. Jenkins | Aug 12, 2026 | FOIA, SEC
As the artificial-intelligence arms race heats up, Meta and Google have turned to Wall Street for help paying the multi-billion-dollar tab. Amid data-center financing terms that even Google’s auditor calls questionable, a Washington securities lawyer whose clients...
by John A. Jenkins | Aug 5, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Stock Market
FOIAengine: Requests from Point72, Sofinnova, Holocene, Triple Gate and Others A review of the latest Freedom of Information Act requests targeting three life-sciences companies – Novo Nordisk (NYSE: NVO); Charles River Laboratories (NYSE: CRL); and iRhythm...
by John A. Jenkins | Jul 30, 2026 | FDA, FOIA, News Media, Pharmaceuticals, Politics
FOIAengine: Multiple News Outlets Sought Details on “Compassionate Use” Within days of a Stat News report describing a highly unusual government decision to grant a 79-year-old patient early access to Eli Lilly’s experimental obesity drug retatrutide, some of the...
by John A. Jenkins | Jul 16, 2026 | FOIA, Politics
FOIAengine: How the GOP’s Senate Campaign Committee Plays the Oppo Game While national reporters were examining Graham Platner’s turbulent personal life, Republican opposition researchers were quietly investigating an entirely different chapter of the Maine Senate...
by Randy Miller | Jul 1, 2026 | Education, FOIA, News Media, Non-Profits, Politics
FOIAengine: Requests Focus on Personnel Levels and Fraud News media and non-profit organizations are using the Freedom of Information Act to monitor the Trump Administration’s dismantling of the Department of Education, according to data compiled by FOIAengine, which...
by John A. Jenkins | Jun 17, 2026 | FOIA, Hedge Funds, SEC, Short-Selling, Stock Market
FOIA Requests Offer Signals, and a Requester Provides Names Activist short seller Andrew Left always had a taste for risk. So, with his freedom and fortune on the line a few weeks ago in a Los Angeles courtroom, Left tried to beat the federal securities fraud charges...
